Serina Therapeutics, Inc.

Q2 2025 13F Holders

Symbol
SER
CUSIP
81751A108
Type
Equity
Class
COM SHS
Num filings
24
Total reported value, excl. options
$2.57 M
Manager Report Date Value ($000) Shares Option Type